20-23 OCTOBER 2025 | VALENCIA
Influenza
RSV Disease
Covid-19
Submission guidelines

Abstract Submission guidelines

Guidelines

We encourage work that introduces new ideas and conceptualisations, research and understandings to the field. Please read the following guidelines carefully before submitting your abstract.

Abstracts can only be submitted online via a conference user profile on https://www.conftool.pro/eswi2025/; submissions by fax, post or email will not be considered. You will need to create an online user profile, but you do not need to pay the registration fee to be able to submit an abstract. Payment will be required at a later stage.

Scientific topics for abstract submission

You may only choose 1 topic. The programme committee can change topic titles, or move submitted abstracts to other topics.

Scientific Programme abstracts

  • Diagnosis and diagnostics in Acute Respiratory Virus Infections (ARVI)
  • Virus structure and replication
  • Virus evolution and strain selection
  • Epidemiology, (sero-)surveillance
  • Mathematical modelling and projections, including limitations
  • Empowering Preparedness: Harnessing Science to Manage Epidemics and Pandemics
  • Innate and adaptive immunity
  • Future vaccination strategies and platforms
  • Virus and host factors in pathogenesis
  • Antiviral and immune therapy
  • Human challenge studies
  • Threats from the animal world
  • Pharmaceutical and non pharmaceutical intervention
  • Clinical manifestations, burden of disease and management
  • Long COVID and other long term effects of ARVI infections

Science Policy Interface (SPI) Programme abstracts

  • Payment models for (National) Immunisation Programmes
  • Respiratory virus infection management and innovations in diagnostics
  • Vaccine platforms and policy development for effective vaccination deployment
  • Burden of disease in acute respiratory virus infections
  • Benefits and challenges of European electronic health registries and immunisation records
  • Pandemic Preparedness
  • Vaccination strategies from a policy perspective

Policies for Abstract Submission

Abstracts should not include libellous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing, to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

Resubmission Policy

An abstract which has been previously published or presented at a national, regional, or international meeting can only be submitted provided that there are new methods, new findings, updated information or other valid reasons for submitting that can be provided by the author.

If preliminary or partial data has been published or presented, the author is required to indicate the details of the publication or presentation as well as the reasons for submitting the abstract to the 10th ESWI Conference. This information will be considered by the Scientific Programme Committee when making final decisions.

If the author neglects to indicate the details of when and where the preliminary or partial data has been published or presented, and the reasons for resubmitting (new methods, new findings, substantially updated information or other valid reasons), and if evidence of previous publication or presentation is found, the abstract will be rejected.

Plagiarism

The conference organisers regard plagiarism as serious professional and academic misconduct. All abstracts are screened for plagiarism, and when identified, the abstract and any other abstracts submitted by the same author are rejected.

Conference Embargo Policy

In the case of the 10th ESWI Conference, as with most scientific/medical conferences, all conference abstracts are released to delegates and media under a strict embargo policy. A detailed breakdown of the embargo variations for different types of abstracts is available below. All regular delegates, presenters and media are asked to respect this policy.

  • Abstracts selected for oral presentations
    Information about the oral abstracts may not be published or presented before the start of the session at the 10th ESWI Conference in which the abstract is being presented.
  • Abstracts selected for Poster Exhibition
    Information about the poster exhibition abstracts may not be published or presented before 08:00 CEST on 21 October 2025.

Abstract Submission Process

Conference User Profile

Before submitting an abstract, a conference user profile needs to be created for the submitting and the presenting author. One or several abstracts can be submitted from the submitting author’s user profile. After an abstract has been created, modifications can be made until the submission deadline.

The final deadline for abstract submission is 16 May 2025, 23:59 CEST.

Abstract Structure and language

All abstracts must be written in English.

Abstracts under all topics and without exception should be structured as follows:

  • Background:
    Indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analysed or evaluated.
  • Methods:
    Describe the setting/location for the study, study design, study population, data collection and methods of analysis used.
  • Results:
    Present as clearly and detailed as possible the findings/outcome of the study, with specific results in summarised form.
  • Conclusions:
    Briefly discuss the data and main outcome of the study. Emphasise the significance for acute respiratory viruses prevention, treatment, care and/or support, and implications of the results.

Word Limits

The abstract text body is limited to 450 words. Titles are limited to 30 words.
A maximum of three tables and three graphs/images can be included (to be uploaded separately): a graph/image (in JPG, GIF or PNG with ideally 600 dpi) counts as 50 words and a table counts as 10 words per row. Social media texts will not be included in the total word count, and should be submitted in the separate field.

Social Media

ESWI may wish to report on your contribution to the 10th ESWI Conference via social media. You are thus invited to provide a 250 characters maximum message that summarises the main content of your work. ESWI will add the following hashtag: #ESWI2025. Please also provide the platform and handle name of the submitting and presenting author.

Font

A standard font, e.g. Arial, should be used when formatting the text. This helps to prevent special characters from getting lost when copying the text to the online submission form.

Submission Confirmation

After submission of the abstract, a confirmation email will be sent to the abstract submitter and all co-authors, if any. To receive this important communication, please ensure that emails from [email protected] are not considered as spam by your email provider. For all authors, please make sure that when you make a user and participation profile to attend the conference, you use the email that was used in the abstract submission because that is the only way you can ensure that the abstract is linked to your profile.

Abstract Review and Selection Process

Abstract Review

All submitted abstracts will go through a double-blinded peer-review process carried out by an international reviewing committee. Each abstract will be reviewed by at least two reviewers.

Abstract Selection

Final selection of abstracts will be done by members of the Programme Committee. The highest-scoring abstracts can be selected for oral presentation. Most of the remaining submissions will be displayed in the Poster Area. The results will not be discussed.

Notification of Acceptance or Rejection to Corresponding Author

Notification of acceptance or rejection will be sent to the submitting (corresponding) author. Please note that only the submitting author will receive mail concerning the abstract and is responsible for informing all co-authors, including the presenting author, of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract. To receive these important communications, please ensure that emails from [email protected] are not considered as spam by your email provider.

Rule of One

Each presenting author may present only one abstract at the conference. The number of submissions is however not limited. Should an author have more than one abstract accepted for presentation, a co-author must be named as presenting author for such abstracts.

Oral and poster presentations

All oral and poster presentations will be done live in Valencia, pre-recorded presentations will not be accepted.

Publication of Accepted Abstracts

Your abstract (oral and poster presentations), if accepted, will appear in its full form in the abstract book and on the virtual conference platform.

It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact in the abstract text will be reproduced as typed by the author. Abstract titles will be subject to a spell check if the abstract is selected for presentation.

Call for Late Breaker Abstracts

Late breaker abstracts present data gathered after the regular abstract submission deadline has closed (16 May 2025) and that is of unquestioned immediate significance. Abstracts that do not comply with this rule will be automatically rejected. Abstracts that do not demonstrate novel findings, and that are too late for the ordinary abstract deadline, will be considered late abstracts and will be automatically rejected.

Late breaker abstract submissions will open on 9 June 2025. The final deadline to submit your late breaker abstract is 8 August, 23:59 CEST.

Check-box

A check-box asking if you had read and comply with the submission policy will be provided as a necessary step before submitting an abstract or a late-breaker abstract. If you are not able to answer yes, your abstract will not qualify for review.

Questions

Any questions regarding the abstract submission should be addressed to [email protected].